TECOS: Randomized Placebo Controlled Clinical Trail to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono or Dual Combination Oral Antihyperglycemic Therapy